[1] YANG JD,HAINAUT P,GORES GJ,et al.A global view of hepatocellular carcinoma:trends,risk,prevention and management[J].Nat Rev Gastroenterol Hepatol,2019,16:589-604.
[2] XING MT,WANG XZ,KIKEN RA,et al.Immunodiagnostic biomarkers for hepatocellular carcinoma(HCC):the first step in detection and treatment[J].Int J Mol Sci,2021,22(11):6139.
[3] 李一凡,杜冀晖,赵慧,等.FLOT2在结直肠癌中的表达及其临床意义[J].医学研究杂志,2021,50(3):6.
LI YF,DU JH,ZHAO H,et al.Expression of FLOT2 in colorectal cancer and its clinical significance[J].Journal of Medical Research,2021,50(3):6.
[4] MAD M,SUN D,WANG J,et al.Long non-coding RNAMIR4435-2HG recruits miR-802 from FLOT2 to promote melanoma progression[J].Eur Rev Med Pharmacol Sci,2020,24(5):2616-2624.
[5] WANG C,ZHU X,MA D,et al.FLOT2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma[J].Am J Cancer Res,2017,7(5):1068-1083.
[6] 雷蕾,张涛,叶斌,等.RNA干扰 FLOT2 基因表达下调 NF-κB信号对胃癌细胞凋亡诱导作用研究[J].胃肠病学和肝病学杂志,2019,28(6):620-624.
LEI L,ZHANG T,YE B,et al.Study of apoptosis-inducing effects of RNA interference with FLOT2 gene expression down-regulating NF-κB signaling in gastric cancer cells[J].Journal of Gastroenterology and Hepatology,2019,28(6):620-624.
[7] WANG YL,YAO WJ,GUO L,et al.Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival[J].Int J Clin Exp Pathol,2015,8:601-607.
[8] 万晓庆,王学健,王艺斐,等.循环microRNAs的外泌形成机制及其对乳腺癌侵袭和转移的影响[J].生物化学与生物物理进展,2017,44(4):269-278.
WAN XQ,WANG XJ,WANG YF,et al.Mechanism of exocytosis formation of circulating microRNAs and its impact on breast cancer invasion and metastasis[J].Advances in Biochemistry and Biophysics,2017,44(4):269-278.
[9] MOU XR,LIU SL.MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting FLOT2[J].BiochemBiophys Res Commun,2016,477:521-526.
[10] CHAKRABORTY E,SARKAR D.Emerging therapies for hepatocellular carcinoma(HCC)[J].Cancers(Basel),2022,14(11):2798.
[11] 吴虹霖,牛翔科,熊燕,等.肝细胞肝癌的免疫治疗现状及研究进展[J].中国免疫学杂志,2021,37(22):2771-2778.
WU HL,NIU XK,XIONG Y,et al.Current status and research progress of immunotherapy for hepatocellular liver cancer[J].Chinese Journal of Immunology,2021,37(22):2771-2778.
[12] TANG A,HALLOUCH O,CHERNYAK V,et al.Epidemiology of hepatocellular carcinoma:target population for surveillance and diagnosis[J].AbdomRadiol(NY),2018,43:13-25.
[13] LI TY,CAO C,XIONG QQ,et al.FLOT2 overexpression is associated with the progression and prognosis of human colorectal cancer[J].Oncol Lett,2019,17:2802-2808.
[14] ROUTLEDGE D,ROGERS S,ONO Y,et al.The scaffolding protein FLOT2 promotes cytoneme-based transport of wnt3 in gastric cancer[J].Elife,2022,11:e77376.
[15] RODRIGUES G,HOSHINO A,KENIFIC CM,et al.Tumor exosomal CEMIP protein promotes cancer cell colonization in brain metastasis[J].Nat Cell Biol,2019,21:1403-1412.
[16] CHEN Y,LI LH,ZHANG JF.Cell migration inducing hyaluronidase 1(CEMIP) activates STAT3 pathway to facilitate cell proliferation and migration in breast cancer[J].J Recept Signal Transduct Res,2021,41:145-152.
[17] 徐晓宏,高守宝,王玥,等.miRNA表达与免疫细胞因子相关性在原发性肝癌早期诊断和预后中的作用[J].中国免疫学杂志,2018,34(1):104-108.
XU XH,GAO SB,WANG Y,et al.Role of miRNA expression and immune cytokine correlation in the early diagnosis and prognosis of primary liver cancer[J].Chinese Journal of Immunology,2018,34(1):104-108.
[18] LI SZ,LI XL,XING XH,et al.miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer [J].Hum Cell,2020,33(4):1165-1175.
[19]孟祥鹏,马佳,王宝胜.lncRNA/miRNA在胰腺癌发生发展中的研究进展[J].现代肿瘤医学,2020,28(22):3999-4002.
MENG XP,MA J,WANG BS.Research progress of lncRNA/miRNA in pancreatic cancer development[J].Modern Oncology,2020,28(22):3999-4002.
[20] 张怀斌,杨国清,梁文强,等.MiR-129-5p靶向HMGB1抑制骨肉瘤细胞增殖和迁移[J].肿瘤防治研究,2022,49(01):5-11.
ZHANG HB,YANG GQ,LIANG WQ,et al.MiR-129-5p targets HMGB1 to inhibit proliferation and migration of osteosarcoma cells[J].Oncology Control Research,2022,49(01):5-11.
[21] MO XX,SHEN XJ,MO XC,et al.CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7/c-Myc-dependent axis[J].Biochem Pharmacol,2023,209:115446.